54
Participants
Start Date
July 31, 2008
Primary Completion Date
September 30, 2011
Study Completion Date
March 31, 2013
RAD001
RAD001 (everolimus) 10mg daily administration orally until disease progression and/or intolerability
Asan Medical Center, Seoul
Lead Sponsor
Asan Medical Center
OTHER